Article
APOE and AβPP gene variation in cortical and cerebrovascular amyloid-β pathology and Alzheimer's disease: a population-based analysis.
Journal of Alzheimer's disease : JAD - 1 Jan 2011
Peuralinna Terhi, Tanskanen Maarit, Mäkelä Mira, Polvikoski Tuomo, Paetau Anders, Kalimo Hannu, Sulkava Raimo, Hardy John, Lai Shiao-Lin, Arepalli Sampath, Hernandez Dena, Traynor Bryan J, Singleton Andrew, Tienari Pentti J, Myllykangas Liisa
Abstract excerpt
Cortical and cerebrovascular amyloid-β (Aβ) deposition is a hallmark of Alzheimer's disease (AD), but also occurs in elderly people not affected by dementia. The apolipoprotein E (APOE) ε4 is a major genetic modulator of Aβ deposition and AD risk. Variants of the amyloid-β protein precursor (AβPP) gene have been reported to contribute to AD and cerebral amyloid angiopathy (CAA). We analyzed the role of APOE and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
